Dose-seeking phase I trials (DSP1T) for currently approved molecular-targeted therapies (MTT): We are still far from using appropriate designs.
Nuria Kotecki
No relevant relationships to disclose
Ahmad Awada
No relevant relationships to disclose
Jacques Bonneterre
No relevant relationships to disclose
Mohamed Hebbar
No relevant relationships to disclose
Antoine Adenis
No relevant relationships to disclose
Alexis B. Cortot
No relevant relationships to disclose
Sophie Cousin
No relevant relationships to disclose
Stephanie Clisant
No relevant relationships to disclose
Alain Duhamel
No relevant relationships to disclose
Andrew Kramar
No relevant relationships to disclose
Nicolas Penel
No relevant relationships to disclose